{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Primary endpoint is bilateral, 12-month Clinically Relevant Salivary Flow (CRSF) by the submandibular and sublingual salivary glands, collectively. Saliva production will be quantified using selective quantitative submandibular sialometry (total collection time of 5 minutes). A CRSF is equivalent to production of 0.05 mL of saliva post-radiation in a 5-minute collection period.","groups":[{"description":"Intensity-Modulated Radiation Therapy (IMRT) 2.0 to 2.2 Gy delivered in 30 fractions + Amifostine 500 mg, 2 divided doses subcutaneously 30-60 minutes prior to IMRT.","id":"OG000","title":"IMRT + Amifostine"}],"populationDescription":"No analysis performed; study terminated early due to change in sponsor.","reportingStatus":"POSTED","timeFrame":"12 months","title":"12-month Clinically Relevant Salivary Flow (CRSF)","type":"PRIMARY"}